Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.
BACKGROUND: Adjuvant chemotherapy (AC) in Stage II Colon Cancer (CC) is still under debate. Choice should be based on patients and disease characteristics. According to guidelines AC should be considered in high-risk T3N0 patients. No data are available for better option in low-risk patients. The ai...
Main Authors: | Roberta Grande, Domenico Corsi, Raffaello Mancini, Donatello Gemma, Fabrizio Ciancola, Isabella Sperduti, Lorena Rossi, Agnese Fabbri, Maria G Diodoro, Enzo Ruggeri, Germano Zampa, Sara Bianchetti, Teresa Gamucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3855068?pdf=render |
Similar Items
-
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.
by: Roberta Grande, et al.
Published: (2016-01-01) -
Longitudinal Assessment of FT3 to FT4 Conversion Ratio in Predicting the Efficacy of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small Cell Lung Cancer: A Propensity-Score Matching Analysis of Data from the National Drug Monitoring Agency
by: Fabrizio Nelli, et al.
Published: (2024-12-01) -
Effects of Acetaminophen Exposure on Outcomes of Patients Receiving Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
by: Fabrizio Nelli, et al.
Published: (2023-09-01) -
Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs
by: Jacob R. Cawley, et al.
Published: (2020-03-01) -
Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study
by: Simon J. Bulley, et al.
Published: (2022-11-01)